Log in to save to my catalogue

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model...

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_acd2b0f06b7943c08611a98b069b169d

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis

About this item

Full title

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2017-10, Vol.16 (1), p.122-122, Article 122

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Previous animal studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1RAs) suppress arterial restenosis, a major complication of angioplasty, presumably through their direct action on vascular smooth muscle cells. However, the contribution of vascular endothelial cells (VECs) to this process remains unknown. In addition, the poten...

Alternative Titles

Full title

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_acd2b0f06b7943c08611a98b069b169d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_acd2b0f06b7943c08611a98b069b169d

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-017-0603-x

How to access this item